Genetic Technology Alert. Glyco-Based Technology Platform for Point-of-Care Diagnostic Applications; Gene Regulation by Controlling Chromatin Loop Formation in Specific Gene Loci; Advancements in Hepatitis B Therapeutics
This issue profiles a glyco-based technology platform for point-of-care diagnostic applications, gene regulation by controlling chromatin loop formation in specific gene loci, and advancements in hepatitis b therapeutics. Strategic partnership details and some important patents have also been included.
Click headings to expand and collapse
Published: 3 Aug 2012
Tools
Features of this research
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..